Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancer

Breast Cancer Research and Treatment

Volumn 39, Issue 3, 1996, Pages 307-313

  De Vries, E G E ^a   Rodenhuis, S ^b   Schouten, H C ^c   Hupperets, P S G J ^c   Dolsma, W V ^a   Lebesque, J V ^b   Blijham, G H ^d   Bontenbal, M ^e   Mulder, N H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

High dose chemotherapy; Metastatic breast cancer

Indexed keywords

ANTINEOPLASTIC AGENT; MELPHALAN; MITOXANTRONE;

ADULT; ARTICLE; ASPERGILLOSIS; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER SURVIVAL; CARCINOMATOUS MENINGITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG MEGADOSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; METASTASIS; MUCOSA INFLAMMATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RELAPSE; REMISSION; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA;

EID: 0029774048     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806158     Document Type: Article

References (19)

1. Eddy DM: High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer. J Clin Oncol 10: 657-670, 1992
2. Falkson G, Tormey DC, Carey P, Witte R, Falkson HC: Long-term survival of patients treated with combination chemotherapy for metastatic breast cancer. Eur J Cancer 27: 973-977, 1991
3. Legha SS, Buzdar AU, Smith TL, Hortobagyi GN, Swenerton KD, Blumenschein GR, Gehan EA, Bodey GP, Freireich EJ: Complete remission in metastatic breast cancer treated with combination drug therapy. Ann Int Med 91: 847-852, 1979
4. Mick R, Begg CB, Antman KH, Korzun AH, Frei E III: Diverse prognosis in metastatic breast cancer: who should be offered alternative initial therapies? Breast Cancer Res Treat 13: 33-38, 1989
5. Falkson G, Gelman R, Falkson CI, Glick J, Harris J: Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study. J Clin Oncol 9: 2153-2163, 1991
6. Mulder POM, Sleijfer DTh, Willemse PHB, De Vries EGE, Uges DRA, Mulder NH: High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors. Cancer Res 49: 4654-4658, 1989
7. WHO Handbook for Reporting Results of Cancer Treatment: WHO Offset Publication no. 48, Nijhoff, Den Haag, 1979
8. Mulder POM, Bouman JG, Gietema JA, Van Rijsbergen H, Mulder NH, Van der Geest S, De Vries EGE: Hyperalimentation in autologous bone marrow transplantation for solid tumors: comparison of total parenteral versus partial parenteral plus enterai nutrition. Cancer 64: 2045-2052, 1989
9. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
10. Vlasveld LT, Delemarre JFM, Beijnen JH, Rodenhuis S: Invasive aspergillosis complicated by subclavian artery occlusion and costal osteomyelitis after autologous bone marrow transplantation. Thorax 47: 136-137, 1992
11. Fischer J, Rose CJ, Rubens RD: Duration of complete response to chemotherapy in advanced breast cancer. Eur J Cancer Clin Oncol 18: 747-754, 1982
12. Williams SF, Gilewski T, Mick R, Bitran JD: High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report. J Clin Oncol 10: 1743-1747, 1992
13. Kennedy MJ, Beveridge RA, Rowley SD, Gordon GB, Abeloff MD, Davidson NE: High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer. J Natl Cancer Inst 83: 920-926, 1991
14. Ayash LJ, Elias A, Wheeler C, Reich E, Schwartz G, Tepler I, Warren D, Lynch C, Gonin R: Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study. J Clin Oncol 12: 37-44, 1994
15. Dillman RO, Barth NM: Intensive chemotherapy with autologous peripheral blood stem-cell rescue in metastatic breast cancer. J Clin Oncol 12: 22-37, 1994
16. Peters WP, Shpall EJ, Jones RB, Olsen GA, Bast RC, Gockerman JP, Moore JO: High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 6: 1368-1376, 1988
17. Mundt AJ, Sibley GS, Williams S, Rubin SJ, Heimann R, Halpern H, Weichselbaum RR: Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy. Int J Radiation Oncol Biol Phys 30: 151-160, 1994
18. Ayash LJ, Wheeler C, Fairclough D, Schwartz G, Reich E, Warren D, Schnipper L, Antman K, Frei E, Elias A: Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem cell support for advanced breast cancer. J Clin Oncol 13: 2034-2049, 1995
19. Dunphy FR, Spitzer G, Fornoff JE, Yau JC, Huan SD, Dicke KA, Buzdar AU, Hortobagyi GN: Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support. Cancer 73: 2157-2167, 1994